Clinical trial
Fibrosis in Renal Allografts
NCT00493194 · University Hospital, Antwerp, Other · Unknown status
Key facts
| NCT number | NCT00493194 |
|---|---|
| Title | Fibrosis in Renal Allografts |
| Official title | Interstitial Fibrosis in Protocol Biopsies of Renal Allografts: A Prospective, Randomised Trial of Sirolimus Versus Cyclosporine.(Fibrasic) |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry Hoffmann-La Roche |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Transplantation, Immunosuppression, Interstitial Fibrosis |
| Intervention type | Drug |
| Interventions | sirolimus, cyclosporine, daclizumab |
| Enrollment | 100 |
| Start date | May 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Jun 28, 2007 |
| Last update posted | Nov 26, 2008 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: